Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged =18 years with stroke, confirmed by cranial CT or MRI examination, and/or meeting the diagnostic criteria outlined in the "Key Diagnostic Points for Major Cerebrovascular Diseases in China 2019" established by the Neurology Branch of the Chinese Medical Association and the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association, or similar criteria. 2. Residents who have resided in the community for >=1 year; 3. Conscious and alert, with no language communication impairment, cognitive impairment, or psychiatric disorder; 4. Patients whose condition is stable and who can walk independently and safely for at least 30metres without the aid of a walking frame; 5. Able to cooperate in completing this intervention study;
Exclusion criteria
Exclusion criteria: 1. Individuals who do not meet the aforementioned diagnostic and inclusion criteria; 2. Patients with unstable vital signs during the trial period, or those with severe hepatic or renal organ disease or malignant tumours; 3. Individuals experiencing an acute exacerbation of an acute or chronic illness; 4. Individuals with severe hearing and speech impairments; 5. Individuals with impaired consciousness who are unable to cooperate with the investigation; 6. Individuals with mental health conditions; 7. The use of VR systems carries the risk of virtual reality sickness. Assessment employs the Simulator Sickness Questionnaire (SSQ), developed by Kennedy et al. in 1993 to evaluate the severity of simulator sickness symptoms. This 16-item scale comprises three subscales: nausea, eye movement, and disorientation. Each item is scored according to symptom severity using the following criteria: None = 0, Mild = 1, Moderate = 2, Severe = 3. The scores for all 16 items are summed to yield a total score ranging from 0 to 48 points. A score of approximately 0–10 indicates mild symptoms, 11–20 denotes moderate symptoms, and 21 or above signifies severe symptoms. Higher scores indicate greater discomfort experienced by the subject within simulator or virtual reality environments; 8. Patients with balance dysfunction arising from other neurological conditions (such as stroke, Parkinson's disease, vestibular disorders, etc.) and musculoskeletal disorders (such as osteoarthritis, etc.);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gait parameters;Dynamic balance capability;Static Balance Ability; | — |
Secondary
| Measure | Time frame |
|---|---|
| dual-task effect;Balance Confidence;Fall Incident;6-Minute Walk Test (6MWT); | — |
Countries
China
Contacts
The Affiliated Hospital of Southwest Medical University